BioTheryX Receives IND Clearance from FDA to Proceed with Phase 1 Study of BTX-1188, a Molecular Glue, for the Treatment of Hematologic and Solid Malignancies

2021-11-02T04:59:45-07:00November 2, 2021|

Enrollment for Phase 1 Clinical Trial to Commence by End of 2021 SAN DIEGO, Nov. 2, 2021 /PRNewswire/ -- [...]